Characterization of Emodin as a Therapeutic Agent for Diabetic Cataract.
about
Phytobioactive compound-based nanodelivery systems for the treatment of type 2 diabetes mellitus - current status.Diosgenin, a Novel Aldose Reductase Inhibitor, Attenuates the Galactosemic Cataract in RatsCataract as Early Ocular Complication in Children and Adolescents with Type 1 Diabetes Mellitus.
P2860
Characterization of Emodin as a Therapeutic Agent for Diabetic Cataract.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Characterization of Emodin as a Therapeutic Agent for Diabetic Cataract.
@en
type
label
Characterization of Emodin as a Therapeutic Agent for Diabetic Cataract.
@en
prefLabel
Characterization of Emodin as a Therapeutic Agent for Diabetic Cataract.
@en
P2093
P2860
P1476
Characterization of Emodin as a Therapeutic Agent for Diabetic Cataract
@en
P2093
Biehuoy Shieh
Daniel V LaBarbera
David Ammar
J Mark Petrash
Linfeng Li
Patricia Lenhart
Theresa M Sanborn
P2860
P304
P356
10.1021/ACS.JNATPROD.6B00185
P577
2016-05-03T00:00:00Z